A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : NOM / normal oral mucosa

[Related PubMed/MEDLINE]
Total Number of Papers: 107
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   NOM  (>> Co-occurring Abbreviation)
Long Form:   normal oral mucosa
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 CD47 as a potential prognostic marker for oral leukoplakia and oral squamous cell carcinoma. CD, LR-OLK, OLK, OSCC
2018 Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders. IHC, OED, OPMDs, OSCC, OSMF, QS
2018 Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study. MVD, OSF
2018 Correlation of matrix metalloproteinase-9 expression with morphometric analysis of mucosal vasculature in oral squamous cell carcinoma, oral epithelial dysplasia, and normal oral mucosa. ECM, MVAP, MVD, OED, OSCC
2018 Evaluation of mast cells in oral premalignant and malignant lesions: A histochemical study. OSCC
2018 Expression of mucin-1 in oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. IHC, MUC1, OSCC
2018 Expression of WNT1 in ameloblastoma and its significance. AB, KCOT, RT-qPCR
2018 Identification of alpha-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis. IHC, MS/MS, OSCC, OSF, OSFWD, OSFWT, RT-PCR, WB
2018 Immunohistochemical evaluation of tumor angiogenesis and the role of mast cells in oral squamous cell carcinoma. MCD, MVD, OSCC
10  2018 Immunohistochemical expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in normal oral mucosa, oral epithelial dysplasia and oral squamous cell carcinoma. EMMPRIN, OED, OSCC
11  2018 Isolation and characterization of cells derived from human epithelial rests of Malassez. ERMs
12  2018 Ki67, CD105, and alpha-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis. OSMF
13  2018 MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma. FFPE, miRNAs, OSCC, qPCR
14  2018 Overexpression of sprouty2 in human oral squamous cell carcinogenesis. MT, NOMPC, OCCLs, OPMDs, OSCCs
15  2018 Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis. EMT, LN, OSCC
16  2017 Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer. EMT, OL, OSCC
17  2017 Identification of a combined biomarker for malignant transformation in oral submucous fibrosis. IMP3, OSF
18  2017 Immunohistochemical analysis of stromal fibrocytes and myofibroblasts to envision the invasion and lymph node metastasis in oral squamous cell carcinoma. alpha-SMA, OSCC
19  2017 Ki67, CD105, and alpha-SMA expressions better relate the binary oral epithelial dysplasia grading system of World Health Organization. LI, LRED, MVD, OED, OPMDs
20  2017 Langerhans cell counts in oral epithelial dysplasia and their correlation to clinicopathological parameters. LCs, OED
21  2017 Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3. NC, OSCC
22  2016 Aberrant DKK3 expression in the oral leukoplakia and oral submucous fibrosis: a comparative immunohistochemical study. DKK3, OLK, OSCC, OSF, TSG
23  2016 CD1a+ dendritic cells in oral lichen planus and amalgam lichenoid reaction. ALR, DCs, OLP
24  2016 Expression of MUC1 mucin in potentially malignant disorders, oral squamous cell carcinoma and normal oral mucosa: An immunohistochemical study. OSCC, PMDs
25  2016 Myeloid cell leukemia-1 is a molecular indicator for malignant transformation of oral lichen planus. Bcl-2, Mcl-1, OLP
26  2015 A histochemical comparison of methyl green-pyronin, and hematoxylin and eosin for detecting apoptotic cells in oral squamous cell carcinoma, oral leukoplakia, oral submucous fibrosis and normal oral mucosa. MGP, OL, OSCC, OSMF
27  2015 Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival. EMT, OSCC
28  2015 Comparing The Efficacy of Hematoxylin and Eosin, Periodic Acid Schiff and Fluorescent Periodic Acid Schiff-Acriflavine Techniques for Demonstration of Basement Membrane in Oral Lichen Planus: A Histochemical Study. BM, HE, OLP, PAS
29  2015 Down-regulation of Akt by methanol extracts of Impatiens balsamina L. promotes apoptosis in human oral squamous cell carcinoma cell lines. DAPI, OSCC
30  2015 Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas. OL, OLP, OSCC, OSMF
31  2015 Expression of phosphorylated Akt/mTOR and clinical significance in human ameloblastoma. AB, OSCC, p-Akt
32  2015 GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma. OED, OSCC, VC
33  2015 Histomorphometric study to compare histological changes between oral squamous cell carcinoma and apparently normal adjacent oral mucosa. ANM, OSCC
34  2015 Minichromosome maintenance-2 (MCM2) expression differentiates oral squamous cell carcinoma from pre-cancerous lesions. LIs, Mcm-2, MCM2, OBK, OED, OSCC
35  2015 Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis. OL, OSMF, PMDs
36  2015 The Activation of NF-kappaB in Infiltrated Mononuclear Cells Negatively Correlates with Treg Cell Frequency in Oral Lichen Planus. NF-kappaB, OLP, Treg
37  2014 Discoidin domain receptors: a promoter of the aggressive behavior of ameloblastomas. ABs
38  2014 Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma. LIs, OSCC
39  2014 Silver binding nucleolar organizer regions dots in oral leukoplakia with epithelial dysplasia and oral squamous cell carcinoma: an in vivo study. ED, OSCC
40  2013 Alterations in the immunoexpression of galectins-1, -3 and -7 between different grades of oral epithelial dysplasia. OED
41  2013 Computational analysis of p63(+) nuclei distribution pattern by graph theoretic approach in an oral pre-cancer (sub-mucous fibrosis). OSCC, OSF, OSFWD, OSFWT
42  2013 COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma. COX, OLP, OSCC
43  2013 Expression of Galpha12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan. OED, OSCC
44  2013 Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study. IHC, OED, OSCC, TLRs
45  2013 Immunohistochemical study of integrin alpha₅beta₁, fibronectin, and Bcl-2 in normal oral mucosa, inflammatory fibroepithelial hyperplasia, oral epithelial dysplasia, and oral squamous cell carcinoma. IFH, OED, OSCC
46  2013 Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. AUC, MD, OSCC
47  2013 Upregulation of epidermal growth factor receptor 4 in oral leukoplakia. EGFR, LP, OLP, PCR
48  2012 Co-expression of Ki-67 and p53 protein in ameloblastoma and keratocystic odontogenic tumor. ABs, DC, FOM, KCOT, LI
49  2012 Comparison of myofibroblasts expression in oral squamous cell carcinoma, verrucous carcinoma, high risk epithelial dysplasia, low risk epithelial dysplasia and normal oral mucosa. alpha-SMA, HRED, LRED, OSCC, VC
50  2012 Computer vision approach to morphometric feature analysis of basal cell nuclei for evaluating malignant potentiality of oral submucous fibrosis. FD, OSFD
51  2012 Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans. MDM2, OIS, OSCC
52  2012 Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation. OSCC, OSMF
53  2012 Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis. Mild ED, Mod ED, MVD, SCC, SED, VEGF
54  2012 Investigation of trefoil factor expression in saliva and oral mucosal tissues of patients with oral squamous cell carcinoma. OSCC, TFF
55  2012 Novel MDM2 splice variants identified from oral squamous cell carcinoma. OSCC, PCR
56  2011 Tumor angiogenesis in keratocystic odontogenic tumor assessed by using CD-105 antigen. DC, KCOT, Ki-67 LI, MVA, MVD, TVA
57  2010 Structural markers for normal oral mucosa and oral sub-mucous fibrosis. OSF
58  2010 Up-regulation of EGF receptor and its ligands, AREG, EREG, and HB-EGF in oral lichen planus. AREG, EGFR, EREG, HB-EGF, OLP
59  2009 A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma. MAGE-A, OSCC, RT-PCR
60  2009 Activation of nuclear factor-kappa B correlates with tumor necrosis factor-alpha in oral lichen planus: a clinicopathologic study in atrophic-erosive and reticular form. NF-kappaB, OLP, TNF-alpha
61  2009 Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. EpCAM, LIs, OSCC
62  2009 Expression of BCL10 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. LI, OSCC
63  2009 Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas. LIs, MCM2, OED, OSCC
64  2009 Improved diagnosis of oral premalignant lesions in submucous fibrosis patients with 5-aminolevulinic acid induced PpIX fluorescence. ED, EH, OSF
65  2009 Increased expression of galectin-1 is associated with human oral squamous cell carcinoma development. Gal-1, OPL, OSCC
66  2009 [Expressions of proliferating cell nuclear antigen, Bcl-2, and Bax in lymphocytes of patients with oral lichen planus]. Bax, Bcl-2, OLP, PCNA
67  2009 [Expressions of receptor-interacting protein and caspase-8 in oral squamous cell carcinoma and oral precancerous lesions]. OLK, OLP, OSCC, RIP
68  2008 An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. ED, EGFR, IHC, OSCC
69  2008 Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. HIF-1alpha, LIs, OSCC
70  2008 Expression of MAGE-A12 in oral squamous cell carcinoma. MAGE-A, OSCC, RT-nPCR
71  2008 Expression of RCAS1 is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. LIs, OSCC
72  2008 NGF and its receptors TrkA and p75NTR in the epithelium of oral lichen. ERY, NGF, OL, p-Akt
73  2008 Quantitative dimensions of histopathological attributes and status of GSTM1-GSTT1 in oral submucous fibrosis. OSCC, OSF
74  2008 [Expression of TGF-beta1, Smad7 and cell apoptosis in epithelium of oral lichen planus]. AI, OLP
75  2007 Changes in the expression of stem cell markers in oral lichen planus and hyperkeratotic lesions. MCSP, OLP
76  2007 Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan. hTERT, OED, SI
77  2007 Expression of vascular endothelial growth factor (VEGF) in normal oral mucosa, oral dysplasia and oral squamous cell carcinoma. SCC, VEGF
78  2007 Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression. OPM, OSCC, TIL, TRAIL
79  2007 Survival signalling in keratinocytes of erythematous oral lichen planus. OL, TNF-alpha
80  2006 Cell proliferation and p53 expression in pseudoepitheliomatous hyperplasia of oral paracoccidioidomycosis. ED, PCMycosis, PEH
81  2006 Cytokeratin expression in pseudoepitheliomatous hyperplasia of oral paracoccidioidomycosis. CKs
82  2006 Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. E-cad, OPLs, OSCC
83  2006 [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma]. AB, KCOT
84  2005 Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer. CRYAB
85  2005 Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing. AQ, ED, EH, LI, OLP, PCNA, SCC
86  2005 Time-resolved autofluorescence spectroscopy for classifying normal and premalignant oral tissues. ED, EH, FDA, VH
87  2004 Expression of caspase-3 and structural changes associated with apoptotic cell death of keratinocytes in oral lichen planus. IIDI, OLP
88  2004 Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. HGF, LIs, OED, OEH, OSCC
89  2004 Identity of TUNEL-positive cells in the oral buccal epithelium of normal mucosa and lichen lesions. ERY, OL
90  2004 [Research on the expression of c-myc mRNA in ameloblastoma]. AB, OKC
91  2003 Auto-fluorescence spectra of oral submucous fibrosis. NADH, OLOSF, OSF
92  2003 Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. ED, LI, SCCs
93  2003 High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. HPV, OSCC
94  2003 In vivo autofluorescence spectroscopy of oral premalignant and malignant lesions: distortion of fluorescence intensity by submucous fibrosis. ED, EH, OSF, SCC
95  2003 The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. Cav-1, LNM, MOSCC, NCMT, OPL, POSCC
96  2003 [Expression of ICAM-1 and VCAM-1 in human ameloblastoma and odontogenic keratocyst]. AB, OKC
97  2002 Prognostic role of p27(Kip1) expression in oral squamous cell carcinoma in Taiwan. ED, SCC
98  2002 Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan. OSF
99  2001 Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation. DYS, SCC, VEGF
100  2000 Expression of proliferating cell nuclear antigen (PCNA) in oral submucous fibrosis, oral epithelial hyperkeratosis and oral epithelial dysplasia in Taiwan. ED, EH, LI, OSF, PCNA